福森药业(01652.HK) 发盈警,预计2024年度亏损介乎1.7亿至2.1亿人民币,相较上年度录得3,630万人民币。主要因营业额大幅下降,但仍保持稳定的毛利率;研发开支增加;及联营威海人生药业的权益减值亏损增加。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/08/29中期业绩无派息2024/03/28末期业绩无派息2023/08/29中期业绩无派息...
Source Link福森药业(01652.HK) 发盈警,预计2024年度亏损介乎1.7亿至2.1亿人民币,相较上年度录得3,630万人民币。主要因营业额大幅下降,但仍保持稳定的毛利率;研发开支增加;及联营威海人生药业的权益减值亏损增加。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/08/29中期业绩无派息2024/03/28末期业绩无派息2023/08/29中期业绩无派息...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.